Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
15 pending office actions • 9 art units • 15 examiners • 0 of 15 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Kyungpook National University Industry- Academic Cooperation Foundation has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single matter is assigned to an individual examiner and a lone art unit. The foundation's current prosecution activity is focused on this individual case.
The busiest examiner, AGUIRRE, AMANDA L, is responsible for the 1 pending office action. With only a single distinct examiner and one distinct art unit involved, the prosecution profile is currently limited to a single point of contact within the patent office's biotechnology division.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (27%) |
| §103 only | 5 (33%) |
| Double-patenting + other | 1 (7%) |
| Multi-statute (no §101) | 5 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, DYLAN C | 1 | 77.0% | +13.7% |
| YU, LIHONG | 1 | 81.6% | +18.7% |
| HUTSON, RICHARD G | 1 | 65.1% | +53.1% |
| UNDERDAHL, THANE E | 1 | 58.8% | +50.8% |
| SEAMAN, D MARGARET M | 1 | 76.5% | +8.0% |
| MEJIAS, SAMANTHA LEE | 1 | 46.4% | +40.9% |
| KHAN, AMINA S | 1 | 47.5% | +43.0% |
| LIPPERT, JOHN WILLIAM | 1 | 58.2% | +40.0% |
| MAYHEW, BRADLEY SCOTT | 1 | — | — |
| CHANG, AUDREY Y | 1 | 46.5% | +20.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19207336 | APPARATUS AND METHOD FOR CHARGING AND DISCHARGING SCHEDULING OF ELECTRIC VEHICLE | WHITE, DYLAN C | — |
| 19085511 | SPECTRUM SHARING METHOD THROUGH FREQUENCY HOPPING IN NON-TERRESTRIAL NETWORKS ARCHITECTURE | YU, LIHONG | — |
| 19099080 | METHOD FOR LIQUEFYING AGAROSE AND PRODUCING NEOAGAROTETRAOSE/NEOAGAROHEXAOSE BY USING THERMOSTABLE GH16B BETA-AGARASE DERIVED FROM NOVEL AGAR-DEGRADING BACTERIUM | HUTSON, RICHARD G | — |
| 18706564 | GH117A a-NEOAGAROBIOSE HYDROLASE DERIVED FROM A NOVEL AGAR-DEGRADING BACTERIUM AND PRODUCING METHOD OF L-AHG USING THE SAME | UNDERDAHL, THANE E | — |
| 18840293 | COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID | SEAMAN, D MARGARET M | — |
| 18290754 | GADOLINIUM-BASED COMPOUND, AND MRI CONTRAST AGENT INCLUDING SAME | MEJIAS, SAMANTHA LEE | — |
| 18832019 | METHOD FOR PREPARING CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS, CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS PREPARED THEREBY, AND FABRIC FOR WOUND HEALING COMPRISING SAME | KHAN, AMINA S | — |
| 18515486 | COMPOSITION FOR INHIBITING SKIN PIGMENTATION THROUGH AUTOPHAGY ACTIVITY CONTAINING PROCYANIDIN A2 AND QUERCETIN, AS ACTIVE INGREDIENTS | MAYHEW, BRADLEY SCOTT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19207336 | APPARATUS AND METHOD FOR CHARGING AND DISCHARGING SCHEDULING OF ELECTRIC VEHICLE | WHITE, DYLAN C | — |
| 19085511 | SPECTRUM SHARING METHOD THROUGH FREQUENCY HOPPING IN NON-TERRESTRIAL NETWORKS ARCHITECTURE | YU, LIHONG | — |
| 19099080 | METHOD FOR LIQUEFYING AGAROSE AND PRODUCING NEOAGAROTETRAOSE/NEOAGAROHEXAOSE BY USING THERMOSTABLE GH16B BETA-AGARASE DERIVED FROM NOVEL AGAR-DEGRADING BACTERIUM | HUTSON, RICHARD G | — |
| 18706564 | GH117A a-NEOAGAROBIOSE HYDROLASE DERIVED FROM A NOVEL AGAR-DEGRADING BACTERIUM AND PRODUCING METHOD OF L-AHG USING THE SAME | UNDERDAHL, THANE E | — |
| 18290754 | GADOLINIUM-BASED COMPOUND, AND MRI CONTRAST AGENT INCLUDING SAME | MEJIAS, SAMANTHA LEE | — |
| 18832019 | METHOD FOR PREPARING CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS, CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS PREPARED THEREBY, AND FABRIC FOR WOUND HEALING COMPRISING SAME | KHAN, AMINA S | — |
| 18295000 | NOVEL COMPOUND COMPRISING ESTER GROUP AND USES THEREOF | LIPPERT, JOHN WILLIAM | — |
| 18254772 | HOLOGRAPHIC PRINTING SYSTEM AND HOLOGRAPHIC PRINTING METHOD USING SAME | CHANG, AUDREY Y | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1761 | 1 |
| 1621 | 1 |
| 2872 | 1 |
| 1672 | 1 |
| 1797 | 1 |
| 1658 | 1 |
| 1684 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19207336 | APPARATUS AND METHOD FOR CHARGING AND DISCHARGING SCHEDULING OF ELECTRIC VEHICLE | WHITE, DYLAN C | — | §101§102 | Non-Final OA | — | Pending | May 13, 2025 |
| 19085511 | SPECTRUM SHARING METHOD THROUGH FREQUENCY HOPPING IN NON-TERRESTRIAL NETWORKS ARCHITECTURE | YU, LIHONG | — | §102§103 | Non-Final OA | — | Pending | Mar 20, 2025 |
| 19099080 | METHOD FOR LIQUEFYING AGAROSE AND PRODUCING NEOAGAROTETRAOSE/NEOAGAROHEXAOSE BY USING THERMOSTABLE GH16B BETA-AGARASE DERIVED FROM NOVEL AGAR-DEGRADING BACTERIUM | HUTSON, RICHARD G | — | §103§112 | Non-Final OA | — | Pending | Jan 28, 2025 |
| 18706564 | GH117A a-NEOAGAROBIOSE HYDROLASE DERIVED FROM A NOVEL AGAR-DEGRADING BACTERIUM AND PRODUCING METHOD OF L-AHG USING THE SAME | UNDERDAHL, THANE E | 1652 | §101§102§103§112 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18840293 | COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID | SEAMAN, D MARGARET M | — | §101§102§112 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18290754 | GADOLINIUM-BASED COMPOUND, AND MRI CONTRAST AGENT INCLUDING SAME | MEJIAS, SAMANTHA LEE | — | §103§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18832019 | METHOD FOR PREPARING CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS, CELLULOSE-POLYVINYL ALCOHOL FABRIC WITH IMPROVED SURFACE CHARACTERISTICS PREPARED THEREBY, AND FABRIC FOR WOUND HEALING COMPRISING SAME | KHAN, AMINA S | 1761 | §102§103 | Final Rejection | — | Pending | Jul 22, 2024 |
| 18295000 | NOVEL COMPOUND COMPRISING ESTER GROUP AND USES THEREOF | LIPPERT, JOHN WILLIAM | — | §103 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18515486 | COMPOSITION FOR INHIBITING SKIN PIGMENTATION THROUGH AUTOPHAGY ACTIVITY CONTAINING PROCYANIDIN A2 AND QUERCETIN, AS ACTIVE INGREDIENTS | MAYHEW, BRADLEY SCOTT | 1621 | §102§103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18254772 | HOLOGRAPHIC PRINTING SYSTEM AND HOLOGRAPHIC PRINTING METHOD USING SAME | CHANG, AUDREY Y | 2872 | §103 | Non-Final OA | — | Pending | May 26, 2023 |
| 18022050 | COMPOSITION FOR DIAGNOSING INFECTIOUS DISEASES COMPRISING AGENT FOR MEASURING EXPRESSION LEVEL OF SREBP2 | BUCKMASTER, MARLENE VRENI | 1672 | §101§112 | Final Rejection | — | Pending | Feb 17, 2023 |
| 18147872 | DISEASE DIAGNOSIS KIT, DISEASE DIAGNOSIS METHOD USING THE DISEASE DIAGNOSIS KIT AND METHOD FOR MANUFACTURING THE DISEASE DIAGNOSIS KIT | MUI, CHRISTINE T | 1797 | §103 | Final Rejection | 42d | Pending | Dec 29, 2022 |
| 17843418 | PD-1-DECORATED NANOCAGES AND USES THEREOF | KOMATSU, LI N | 1658 | §103 | Final Rejection | 3d overdue | Pending | Jun 17, 2022 |
| 17642250 | USE OF ENDOTHELIN RECEPTOR INHIBITOR FOR INHIBITING EXOSOME SECRETION OR INHIBITING PD-L1 EXPRESSION | BUNKER, AMY M | 1684 | §103 | Non-Final OA | — | Pending | Mar 11, 2022 |
| 17629607 | BIOCOMPATIBLE HYDROGEL COMPRISING HYALURONIC ACID AND POLYETHYLENE GLYCOL | MATTISON, LORI K | 1619 | §103DP | Non-Final OA | 96d overdue | Pending | Jan 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial